Important safety considerations include: Pancreatitis : Seek urgent medical attention for severe, persistent abdominal pain (which may radiate to the back), with or without vomiting Gallbladder disease : Report right upper quadrant pain, fever, or yellowing of the skin/eyes Diabetic retinopathy complications : Be aware that rapid improvement in blood glucose can temporarily worsen retinopathy
However, severe or persistent abdominal pain, persistent vomiting, signs of dehydration, blood in stools, or symptoms suggestive of pancreatitis or gallbladder disease require prompt medical assessment
FIGURE 6 4 Discussion In this study, we explored the protective effect of empagliflozin (an SGLT2i) and/or semaglutide (a GLP-1RA) with a RAS blocker on kidney and heart of uninephrectomized db/db mice
In May 2025, CVS Caremark announced that anti-obesity (AOM) tirzepatide (sold as Zepbound) would be removed from its preferred formulary effective July 1, 2025, with AOM semaglutide (sold as Wegovy) designated as the preferred alternative
What benefits are associated with Dihexa
After the initial treatment period, your doctor may increase the dose to Ozempic 0.5 mg , and later to Ozempic 1 mg if additional blood sugar control or weight loss support is needed
